Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Colorectal Cancer
  •  Gastrointestinal Cancer
  •  Head and Neck Oncology
  •  Bladder Cancer
  •  Kidney Cancer
  •  Lymphoma
  •  Prostate Cancer
  •  Surgical Oncology

Abstract

Citation: Clin Oncol. 2016;1(1):1081.DOI: 10.25107/2474-1663.1081

Outcome of Pediatric Patients with Low-Grade Astrocytoma of the Brain and Spinal Cord

Taneva M and Johnston DL


Division of Pediatric Hematology/Oncology, Children’s Hospital of Eastern Ontario, Canada

*Correspondance to: Donna Johnston 

 PDF  Full Text Research Article | Open Access

Abstract:

Background: Low-grade astrocytomas are the most common pediatric central nervous system tumours. They can occur anywhere in the central nervous system and are often challenging to treat.
Methods: A retrospective review to compare the response to therapy for spinal cord astrocytomas to that of brain astrocytomas.
Results: Five patients had low-grade spinal cord astrocytoma and 43 had low-grade brain astrocytoma. One spinal cord and 16 brain patients underwent complete resection, and 2 and 20, respectively, partial resection. Of the 56% total patients with a partial resection, 31.8% and 4.5% received adjuvant chemotherapy and radiotherapy, respectively. 14% of all patients received chemotherapy, without resection. Three patients with spinal cord tumours underwent subtotal resection/biopsy followed by chemotherapy. They showed a mean tumour decrease of 36.9%, and none relapsed. The remaining patients showed tumour progression which responded to chemotherapy. Ten brain tumour patients received chemotherapy and 4 received radiation. Tumour size decreased by 44.5% with surgery/adjuvant therapy, and 27.1% with adjuvant therapy alone. Ten patients relapsed at a mean of 9.6 months. Those treated underwent resection (n=3) or adjuvant therapy (n=5) and 4 relapsed again. Conclusions: All patients with low-grade spinal cord astrocytomas responded to chemotherapy and none received radiation while 81.8% of those with brain astrocytoma responded to adjuvant therapy including radiation.

Keywords:

Low-grade astrocytoma; Chemotherapy; Therapy response

Cite the Article:

Taneva M, Johnston DL. Outcome of Pediatric Patients with Low-Grade Astrocytoma of the Brain and Spinal Cord. Clin Oncol. 2016; 1: 1081.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Erlotinib Treatment Beyond Progression in EGFR Mutant Patients Who Have Responded to EGFR TKIs in Stage IIIB/IV NSCLC: An Open Label Randomized Trial
 Abstract  PDF  Full Text
Application of First-Line Steady-State Mobilization vs. Conventional Chemotherapy Mobilization for Peripheral Hematopoietic Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma Patients
 Abstract  PDF  Full Text
View More...